We are happy to report good ongoing progress with AURORAX-0087A: not only has the study remained active during these past months, but we have also continued to recruit patients and move ahead with the set-up of the participating sites. We can now confirm that all Sites in AUR87A have received regulatory and ethics committee approval, and all but one site are now actively recruiting: this is a great achievement and a testament of the continued hard work and dedication demonstrated by our collaborating Principal Investigators, their site teams, and our business partners.
